Maxxon Biotech Private Limited
About Maxxon Biotech Private Limited
Data last updated:
Maxxon Biotech Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 July 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U74999RJ2018PTC061873. Its GSTIN is 08AALCM9812C1ZD (Rajasthan). The company holds 5 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3.5 Lakh. It is led by directors Bharati Garg and Pradeep Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Godam Plot No. 9A South Part Truck Stand Transport Nagar Delhi Bye Pass Road, Jaipur, Rajasthan, India – 302004.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.43 Cr, a growth of 47% compared to the previous year. For the same year it recorded a net profit of ₹38.81 Lakh (net margin 5.2%) and EBITDA of ₹52.98 Lakh (EBITDA margin 7.1%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 6% over five years.
The company has about 1 employee on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹2 Cr on record. The company has 1 deal on record (1 rights issue); the latest was in October 2021. Its 5 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 4 larger and 1 smaller; the largest is Medicross Pharma-Chem Limited with revenue of ₹7.48 Cr.
Company details
Contact details
Maxxon Biotech Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressGodam Plot No. 9A South Part Truck Stand Transport Nagar Delhi Bye Pass Road, Jaipur, Rajasthan, India – 302004
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Maxxon Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Maxxon Biotech Private Limited
FY 2025 filings availableMaxxon Biotech Private Limited reported revenue of ₹7.43 Cr (up 47% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 47% growth in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹52.98 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹38.81 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.1% | ||||
| Net Profit Margin | 5.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Maxxon Biotech Private Limited, buy the company report.
Board of directors of Maxxon Biotech Private Limited
Maxxon Biotech has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bharati Garg | Director | 25 Jul 2018 | 8 Years 3 Months | Current |
| Pradeep Gupta | Director | 25 Jul 2018 | 8 Years 3 Months | Current |
Peer comparison
Maxxon Biotech Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medicross Pharma-Chem Limited | ₹7.48 Cr (FY 2025) | 6.0% | Delhi, India | |||
| Dr.Goyal Medical Private Limited | ₹7.46 Cr (FY 2024) | 6.0% | Ahmedabad, Gujarat, India | |||
| Franklin Healthcare Private Limited | ₹7.45 Cr (FY 2024) | 17.0% | Roorkee, Uttarakhand, India | |||
| Oxygen Lifeline Private Limited | ₹7.44 Cr (FY 2019) | 70.0% | Ahmedabad, Gujarat, India | |||
| Maxxon Biotech Private Limitedthis company | ₹7.43 Cr (FY 2025) | ₹38.81 Lakh | 5.2% | 47.0% | 1 | Jaipur, Rajasthan, India |
| Asvin Diagnostics Private Limited | ₹7.42 Cr (FY 2025) | 23.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Maxxon Biotech Private Limited, buy the company report.
Auditor
Maxxon Biotech Private Limited is audited by Ashish Sogani and Company for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Ashish Sogani and Company | FY 2023 | 016546C |
Shareholding
The shareholding of Maxxon Biotech Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Maxxon Biotech Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Oct 2021 | 100499141 | Others | ₹2 Cr | Satisfied |
To see the full charge records of Maxxon Biotech Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Maxxon Biotech Private Limited has 1 deal on record (1 rights issue); the latest was in October 2021.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2021 | Rights issue | ₹45.3 Lakh | Investors: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Maxxon Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maxxon Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Maxxon Biotech Private Limited has a workforce of 1 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
GST
Maxxon Biotech has 5 GST registrations: 2 active and 3 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AALCM9812C1ZD | Rajasthan | Active | 14 Sep 2018 |
| 36AALCM9812C1ZE | Telangana | Active | 20 Sep 2019 |
To see the full GST registrations and return filing status of Maxxon Biotech Private Limited, buy the company report.
Recent activity
Maxxon Biotech Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Brij Gopal Sharma ceased to be Director on 25 Nov 2020.
Frequently asked questions
Maxxon Biotech is an active private limited company based in Jaipur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 July 2018 (8+ years old) and is registered under CIN U74999RJ2018PTC061873.
Maxxon Biotech has 2 current directors:
- Bharati Garg - Director
- Pradeep Gupta - Director
The latest financial statements of Maxxon Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Maxxon Biotech is 08AALCM9812C1ZD, registered in Rajasthan. The company has 5 GST registrations in all, of which 2 are active and 3 are cancelled or inactive. Other active GSTINs include 36AALCM9812C1ZE (Telangana).
The CIN (Corporate Identification Number) of Maxxon Biotech is U74999RJ2018PTC061873. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxxon Biotech was incorporated on 25 July 2018, making it 8+ years old. It is registered with the Registrar of Companies, Jaipur.
Maxxon Biotech has 1 deal on record (1 rights issue); the latest was in October 2021.
The peers of Maxxon Biotech by revenue are Medicross Pharma-Chem Limited, Dr.Goyal Medical Private Limited, Franklin Healthcare Private Limited, Oxygen Lifeline Private Limited, Asvin Diagnostics Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Brij Gopal Sharma ceased to be Director on 25 Nov 2020. Bharati Garg was appointed as Director on 25 Jul 2018. Pradeep Gupta was appointed as Director on 25 Jul 2018.
The registered office of Maxxon Biotech is at Godam Plot No. 9A South Part Truck Stand Transport Nagar Delhi Bye Pass Road, Jaipur, Rajasthan, India – 302004.
Maxxon Biotech operates in the pharma industry, in the pharmaceutical retailers and distributors segment.